A. Dasgupta et Wc. Thompson, CARBAMAZEPINE SALICYLATE INTERACTION IN NORMAL AND UREMIC SERA - REDUCED INTERACTION IN UREMIC SERA, Therapeutic drug monitoring, 17(2), 1995, pp. 199-202
Displacement of phenytoin and valproic acid by salicylate have been de
scribed. We studied carbamazepine-salicylate interactions in normal an
d uremic sera, which have not been studied. Salicylate caused signific
ant displacement of carbamazepine from protein binding, leading to hig
her concentrations of free carbamazepine. The concentrations of free c
arbamazepine were always significantly higher in uremic sera than in n
ormal sera. However, when uremic sera were supplemented with both carb
amazepine and salicylate, we observed a much lower displacement of car
bamazepine and only a slight increase in free carbamazepine concentrat
ion. Treatment of uremic sera with activated charcoal corrected the bi
nding deficiency for carbamazepine. Known uremic compounds like hippur
ic acid and indoxyl sulphate can only partly explain the observed disp
lacement of carbamazepine in uremic sera. We conclude that salicylate
displaces carbamazepine from protein binding in normal sera, but this
interaction is significantly reduced in uremic sera.